Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 16, 2019
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Artificial intelligence and cancer
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations
Reducing the cancer burden for women around the globe
Dr. Nancy Davidson on improving outcomes for women with breast, lung and colorectal cancer
Blood clots: What cancer patients need to know
A common side effect of cancer and its treatment gets renewed attention and potential new therapies
Q&A: A new focus on small cell lung cancer
Dr. David MacPherson discusses the state of small cell lung cancer research, how his lab is tackling this deadly disease, and what makes him excited for the future
Exploring why people with HIV have a higher lung cancer risk
120 volunteers to enroll in Seattle-area study of cancer-related gene mutations
7 lung cancer misconceptions
Myths and misinformation still keep many people in the dark – and that’s bad news for their health
Path to a targeted treatment for small-cell lung cancer?
Researchers show how common mutation in SCLC makes mouse tumors more vulnerable to certain cancer drugs
Lung cancer: to screen or not to screen
From the Roth Group, Public Health Sciences Division
Dr. Alice Berger receives $200K grant for lung cancer research
Award to fund genome sequencing on lung tumors found in female ‘never-smokers’
Fred Hutch metastatic breast cancer researchers awarded nearly $500K
Celebrating faculty and staff achievements
The lung cancer blame game
The shame, blame and stigma surrounding this deadly disease affects everything from patient follow-through to research funding
A risky variant of TDP1 in lung cancer survival
From the Chen Group, Public Health Sciences Division.
A smoky immune response in lung cancer patients
From the Houghton lab, Clinical Research Division
Good News: Dr. Sue Biggins named a 2017 ASCB fellow
Celebrating faculty and staff achievements
Links between air pollution and cancer risk
An environmental exposure researcher on how the air we breathe can raise risk of lung and other cancers — and what to do about it
Our smoking cessation expert answers questions on e-cigarettes and the FDA's push to limit nicotine
Smoking cessation expert Dr. Jonathan Bricker weighs in on new studies and a federal effort to regulate an ‘astonishingly addictive’ drug
The tumor microenvironment: How cancer fools healthy neighboring cells
‘Tumor microenvironment’ research underscores why we need cancer immunotherapy — and how to make it work for more patients
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight
A model for progress in lung cancer survival
From the Roth and Ramsey Labs, Public Health Sciences Division
Love in the time of cancer — three couples find romance despite disease
Getting dumped after diagnosis isn’t the only story out there; meet three couples who found romance despite disease
New cancer mortality rate study highlights health disparities across the country
New study on county-by-county cancer deaths highlights significant health disparities across the nation
A Q&A with immunotherapy researcher Dr. Rachel Perret
As part of a world-class immunotherapy research team, Perret is working her ‘dream job’ — trying to bring T-cell therapy to all who need it